Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly-L-lysine (PLL) is a synthetic cationic homopolypeptide consisting of repeating units of the essential amino acid L-lysine [PubChem]. It is primarily recognized for its ability to mediate strong electrostatic interactions with negatively charged molecules and surfaces, such as the phosphate backbone of DNA or the glycocalyx of cell membranes [ScienceDirect]. In biomedical research, PLL is extensively used as a coating for glass and plastic cultureware to promote cell attachment and spreading [Sigma-Aldrich]. Beyond its role as a laboratory reagent, PLL serves as a versatile scaffold for drug and gene delivery systems, forming 'polyplexes' that protect nucleic acids from enzymatic degradation and facilitate their cellular uptake [PubMed]. It also possesses intrinsic antimicrobial properties, particularly against Gram-positive and Gram-negative bacteria, by disrupting the integrity of the bacterial cell wall through charge-based interactions [NIH]. However, the clinical utility of PLL is often limited by its molecular weight-dependent cytotoxicity and potential to induce hemolysis or systemic inflammatory responses [Journal of Controlled Release].
Poly-L-lysine acts via electrostatic attraction between its positively charged epsilon-amino groups and negatively charged biological components, such as the phosphate backbone of nucleic acids or the glycocalyx of cell membranes [ScienceDirect, NIH].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly-L-lysine (PLL).